Teva Pharmaceutical Industries Ltd. (TEVA) Prices $4.9 Billion Senior Notes Offering
Teva Pharmaceutical Industries Ltd. (TEVA) successfully priced an offering of approximately $4.9 billion in senior notes. The proceeds are expected to fund redemptions of certain existing notes and other corporate purposes.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.